After proper reconstitution, the product is injected into the deep dermis or subcutaneous tissue. The PLLA microparticles act as a biostimulatory framework, encouraging fibroblasts to produce new collagen over time. As the PLLA is slowly and safely biodegraded, the newly formed collagen replaces lost volume and improves skin structure and firmness.
Lanluma X is particularly suitable for larger treatment areas and for patients with moderate to severe volume loss who are seeking progressive enhancement rather than instant volumisation. The product is a CE-marked medical device and is intended exclusively for professional use by trained medical practitioners, in compliance with EU and German medical device regulations.
Lanluma X provides progressive, long-term aesthetic improvement by addressing the underlying causes of ageing-related volume loss. It is indicated for:
- Deep wrinkles and folds
- Facial volume loss
- Skin laxity and reduced firmness
- Volume restoration in selected body areas
Common treatment areas include the cheeks, jawline, chin, nasolabial folds, as well as hands, neck, décolleté, buttocks, thighs, and other body zones requiring volumisation and skin quality improvement.
With course-based treatment, Lanluma X may deliver:
- Gradual and natural volume restoration
- Improved skin density, firmness, and elasticity
- Smoother skin texture and reduced wrinkle depth
- Long-lasting collagen-driven rejuvenation
- Natural results without abrupt or excessive volume
Visible results typically develop over 2–3 months as collagen production increases. Depending on individual factors and treatment protocol, results can last up to 24 months.
Treatment protocols usually involve 1–3 sessions, spaced several weeks apart, with the exact approach determined by the treating healthcare professional.